Corcept Therapeutics, Inc. (CORT)
42.49
+0.51
(+1.21%)
USD |
NASDAQ |
Apr 02, 16:00
42.47
-0.02
(-0.05%)
After-Hours: 20:00
Corcept Therapeutics Total Liabilities (Quarterly) : 190.22M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | 601.51M |
| Merck & Co., Inc. | 84.20B |
| Terns Pharmaceuticals, Inc. | 18.73M |
| Integer Holdings Corp. | 1.664B |
| Ultragenyx Pharmaceutical, Inc. | 1.605B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 838.03M |
| Shareholders Equity (Quarterly) | 647.80M |
| Debt to Equity Ratio | 0.0094 |
| Current Ratio | 2.892 |
| Net Debt Paydown Yield | 0.00% |